Any treatment-related adverse event, no. (%)
|
Any grade
|
756 (66)
|
734 (64)
|
128 (20)
|
Grade ≥ 3
|
296 (26)
|
275 (24)
|
42 (6)
|
Serious adverse event
|
225 (20)
|
218 (19)
|
15 (2)
|
Immune-related adverse event, no. (%)
|
Any grade
|
569 (49)
|
550 (48)
|
65 (10)
|
Grade ≥ 3
|
211 (19)
|
211 (18)
|
20 (3)
|
Treatment-related adverse event/serious adverse event leading to discontinuation, no. (%)
|
Any grade
|
158 (14)
|
148 (13)
|
14 (2)
|
Grade ≥ 3
|
102 (9)
|
99 (9)
|
4 (1)
|
Treatment-related adverse event/serious adverse event leading to death,e no. (%)
|
Any grade
|
22 (2)
|
21 (2)
|
1 (<1)
|
Grade ≥ 3
|
17 (1)
|
16 (1)
|
1 (<1)
|